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Summary The prognostic value of several clinical and histopathological characteristics has been evaluated in
patients with Dukes' B and C carcinoma of the rectum and the rectosigmoid. Data on 260 Dukes' B and 208
Dukes' C tumours entered into a prospective, randomized clinical trial of post-operative radiotherapy (5OGy
given with 2Gy/fraction in an overall time of 7 weeks) were analyzed by means of the Cox proportional
hazards model. The Dukes' stages B and C were analyzed in two separate multivariate analyses. In patients
with Dukes' B tumours, a poor prognosis was associated with age above 60, perineural and venous invasion,
tumour located <Ocm from the anal verge and elevated pre-operative carcinoembryonic antigen (CEA)
(>3.2 ngml-1). In patients with Dukes' C tumours, perineural and venous invasion, tumour located <Ocm
from the anal verge, and elevated pre-operative CEA were associated with a poor prognosis. In addition, a
large tumour diameter had a strong, negative influence on the prognosis. Males seemed to have a poorer
prognosis than females among the Dukes' C patients. Resection of neighbouring organs was also associated
with a poor prognosis in this stage.
Post-operative radiotherapy as administered in the present series had no significant influence on prognosis.
Based on the derived prognostic models patients with a hazard of death above the median in each stage were
selected. A separate analysis of the survival in these high risk patients showed no survival benefit from
radiotherapy.
The proportional hazards model may be a useful tool in selecting patients for more aggressive adjuvant
treatment.
The role of adjuvant therapy in colorectal cancer remains
controversial. The Danish Cooperative Group on Colorectal
Cancer (CRES) conducted a prospective, randomized trial to
elucidate whether the deleterious effects of post-operative
radiotherapy were justified by an improved survival and/or a
delay in the first recurrence (Balslev et al., 1982, 1986). Even
after the inclusion of 494 patients with Dukes' B and C
tumours, no significant improvement in the survival after
post-operative radiotherapy was demonstrated. The conclu-
sion from this series was that the majority of Dukes' B and
C colorectal cancers did not benefit from post-operative
radiotherapy, at least when the dose was 50Gy given in 25
fractions in an overall treatment time of seven weeks. More
intensive radiotherapy should be carefully considered taking
into account the relatively high level (about 10%, Balslev et
al., 1986) of severe complications. However, large variations
in prognosis among Dukes' B or C colorectal cancer patients
have been demonstrated. The present regression analysis of
survival data was undertaken to define a subset of patients
with a potentially poor prognosis in whom more aggressive
adjuvant therapy nay be indicated.
Materials and methods
The randomized multicentre study of post-operative radio-
therapy in Dukes' B and C carcinoma of the rectum and the
rectosigmoid was open for patient intake during the period
September 1979 to March 1984 (Dukes' B) or March 1985
(Dukes' C). The original classification of Dukes' was
employed, with B tumours defined as having penetrated the
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bowel wall completely, and C tumours as having metasta-
sized to the regional lymph nodes regardless of the degree of
bowel wall penetration. No subdivision of Dukes' stages was
used. A total of 497 patients with Dukes' B, and 364
patien-ts with Dukes' C tumours were referred to five major
surgical departments and operated for cure, and these com-
prised the candidates for randomization. Of these 276
Dukes' B and 218 Dukes' C were randomized. Exclusion
criteria were: tumour above the pelvis, patient aged >80
years, non-radical surgery, bedridden more than 50% of day
20-25 days after surgery, post-operative complications,
previous cancer within 5 years and previous radiotherapy.
A detailed description of material and methods has been
published in Balslev et al. (1982, 1986). In the group of
patients randomized to receive radiotherapy 92% actually
received treatment, and 84% were treated to the prescribed
target dose. A detailed account of escape clauses in the
present series has recently been given by Kronborg et al.
(1988).
A number of clinical, pathological and histochemical
parameters were evaluated prospectively and stored in a data
base for subsequent analysis. In addition, carcinoembryonic
antigen (CEA) was measured with the Hoffman-La Roche
sandwich-enzyme immunoassay immediately before surgery
and at each follow-up. Only the pre-operative CEA is
included in the analysis of prognostic factors.
The present analysis is performed on patient data trans-
ferred from the CRES data base in Odense to the computer
facility at the Radiophysics Laboratory in Aarhus.
Total group, analysis group
Patient characteristics for all randomized patients are given
in Table I.
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Table I Patient characteristics for 494 Dukes' B and
rectosigmoid
Characterstic
Sex Male
Female
Complicating disease Yes
No
Type of resection Abdomino perineal
low anterior
high anterior
Resection of Yes
neighbour organs No
Localization I Above the peritoneal
reflection
Below
Localization II Rectosigmoid
Rectum
Localization III
distance from l10cm
anal verge > 10cm
Histologic grade I
II
III
IV
Perineural invasion Yes
No
Venous invason Yes
No
Pre-operative CEAa 0-3.1 ngml -
3.2-7.0ngml-
7.1 + ngml-P
Ageb
Maximum tumour diameterb
aAnalysis group only (see text); bMean+ 1 s.d.
C carcinoma of the rectum and the
Dukes' B
patients %
155 (56%)
121 (44%)
71 (26%)
205 (74%)
82 (30%)
108 (39%)
86 (31%)
32 (12%)
244 (88%)
141 (51%)
135 (49%)
72 (26%)
204 (74%)
93 (34%)
183 (66%)
11 (4%)
170 (62%)
95 (34%)
0
47 (17%)
229 (83%)
68 (25%)
208 (75%)
147 (57%)
62 (24%)
51 (20%)
64.6+9.7 years
6.0+5.8cm
Dukes' C
patients %
103
115
64
154
83
92
43
23
195
(47%)
(53%)
(29%)
(71%)
(38%)
(42%)
(20%)
(11%)
(89%)
88 (40%)
130 (60%)
36 (17%)
182 (83%)
105 (48%)
113 (52%)
4 (2%)
104 (48%)
106 (49%)
4 (2%)
82 (38%)
136 (62%)
67 (31%)
151 (69%)
90 (43%)
46 (22%)
72 (35%)
63.6+9.8 years
5.7+3.9cm
The analysis group consisted of all randomized patients
with recorded values of all relevant parameters for the
analysis of prognostic factors. Sixteen Dukes' B and ten
Dukes' C patients were excluded from the proportional
hazards analysis because no CEA measurement was recorded
within the time interval from one week before to one week
after the operation. The group submitted to regression
analysis thus consisted of 260 Dukes' B and 208 Dukes' C
tumours.
Statistical method
The effect of single variables on survival was investigated by
single-parameter analyses using the product-limit estimate of
the survivorship function (Kaplan & Meier, 1958) and the
log-rank test for statistical significance (Mantel, 1966). Esti-
mated 5-year survival is specified + the standard error of the
estimate. A significance level of 0.05 was employed.
A multivariate regression analysis of survival data was
performed using the Cox proportional hazards model (PHM)
(Cox, 1972) implemented as a FORTRAN program based
on the code given by Kalbfleisch and Prentice (1980). The
proportional hazards assumption was tested graphically. A
more detailed description of the procedure has been given
recently (Bentzen et al., 1988).
The covariates, i.e., the clinical and histopathological
parameters to be tested for their prognostic value, were
selected based on the experience from published prognostic
studies (Chapuis et al., 1985; Sugarbaker et al., 1985).
Inclusion of covariates in the regressional model was done in
a step-wise manner guided by single parameter analyses.
After establishing a basic model including perineural and
venous invasion, tumour localization and pre-operative CEA,
additional covariates were added one by one to test if any of
these had significance. Covariates with a P-value <0.1 were
included in the model if prior knowledge indicated their
possible prognostic significance.
The endpoint used was death with cancer. Patients still
alive at the time of analysis (September 1986) and patients
dying from intercurrent disease with no evidence of cancer at
autopsy were treated as censored observations (Table II). All
other patients were considered dead from cancer, thus
obtaining a conservative estimate of the frequency of cancer
deaths. No patient was lost for follow-up. Test of signifi-
cance as well as the multivariate analysis were based on the
full observation time available (i.e., up till 7 years).
Post-operative radiotherapy
All patients were treated with 8-16 MV photons in the prone
position either with a three-field technique using one poster-
ior and two parallel opposing lateral wedged fields or with a
four-field technique using two parallel opposing lateral fields
and two parallel opposing anterior-posterior fields. All fields
were treated in each treatment session. The target volume
specified by the CRES protocol included the pelvic cavity
with the proximal field limit at the mid-level of the 5th
lumbar vertebra. The distal limit was the lower margin of
the obturator foramen in patients having anterior and low
anterior resection, whereas in patients having abdominoperi-
neal resection the distal limit included the perineal region.
Laterally, the pelvic brim was included with a margin of 1.5
to 2cm. The lateral fields included the posterior surface of
the symphysis and the whole sacral cavity with proximal and
distal limits matching those of the posterior field. Individu-
ally shaped shielding blocks were made to encompass the
target defined on conventional simulator radiographs with a
2-3cm margin.
A total target dose of 50Gy was given with 2Gy/fraction,
5 days a week. The irradiation was given as a split-course,PROGNOSTIC FACTORS IN COLORECTAL CANCER 197
Table II Carcinoma status at time of death/censoring
Dukes' B Dukes' C
Dead with verified carcinoma 59 (21%) 110 (50%)
Dead - no autopsy 10 (4%) 12 (6%)
Dead - no carcinoma at autopsya 10 (4%) 9 (4%)
Still alivea 197 (71%) 87 (40%)
aTreated as censored observations.
with a 2 week break after 30Gy. Radiotherapy was started
within 30 days after surgery or in patients with surgical
complications within 60 days after surgery.
A random sample of 45 simulator films and port films
were reviewed by the radiotherapy group. In all but two
cases (96%) the target volume was judged to be adequately
treated. In one patient, the perineal region was erroneously
excluded from the field; in the other the margin to the sacral
bone was insufficient (-0.5cm).
Results
Figure 1 shows the product-limit estimate of the survivorship
functions for Dukes' B and Dukes' C patients with or
without post-operative radiotherapy. The overall 5-year
actuarial survival was 68.9 +4.6% in Dukes' B patients
randomized to receive radiotherapy (+RT) and 71.4+4.7% in
those randomized to surgery alone (-RT) the difference
being insignificant (2=0.83, P=0.36). In Dukes' C patients
the 5-year survival was 36.3+5.3% (+RT) and 23.4+6.0%
(-RT). Again the difference was not statistically significant
(X2=O.Ol, P=0.92).
Single parameter analyses were performed to establish an
appropriate scoring of age (Table III) and tumour size
(Table IV) for the PHM analysis.
In the Dukes' B group old patients (age above 70) had a
significantly poorer prognosis than younger patients. A
linear test-for-trend based on the log-rank test (Tarone,
1975) yielded a highly significant P value (x2= 11.2,
P=0.0008). Increasing tumour size evaluated as the maxi-
mum diameter of the tumour seemed to be associated with
an improved prognosis, but a linear test-for-trend yielded a
non-significant P value of 0.11 (X2 =2.55).
Age had no significant prognostic value in patients with
Dukes' C tumours (test-for-trend x2=0.0, P= 1.0). All
10-year age groups had comparable 5-year survival around
30% and median surival around 3 years. Increasing tumour
size seemed to worsen prognosis, but again the test-for-trend
was non-significant (X2 =2.71, P=0.10).
Regression analysis
Patients with Dukes' B and Dukes' C tumours were analyzed
as two separate groups. Although this strategy may lead to
some loss of statistical power compared to the technically
feasible stratified PHM analysis (Kalbfleisch & Prentice,
1980), it was preferred here in order to avoid the assumption
about identical regression coefficients for the two stages. A
partial motivation for this choice is the apparent interaction
between age and stage (Table III) and tumour size and stage
(Table IV) where opposite trends are seen in the two stages.
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Figure 1 Kaplan-Meier estimate of survival after adjuvant
radiotherapy and resection alone in 276 patients with Dukes' B
and 218 patients with Dukes' C tumours.
Table III 5-year survival according to age-group
Dukes' Ba Dukes' C
5-year No. of 5-year No. of Median
survivalb patients survivalc patients (years)
20-50 81.6+8.1% 22 24.7+11.9% 21 3.16
51-60 84.3+5.1% 56 11.4+ 7.1% 50 3.25
61-70 74.4+4.9% 117 35.0+ 5.9% 89 3.06
71-80 49.3+7.0% 81 37.2+ 7.5% 58 3.32
aMedian survival not evaluable; bTest-for-trend (X2 = 11.2,
P=0.0008); cTest-for-trend (xI=0.0, P=1.0).
Such interactions may be included in the modelling but will
produce a more complex final model. The scoring of
covariates is given in Table V. Graphical tests showed that
the proportional hazards assumption was reasonable. Results
for each covariate are briefly presented here.
Patient age was entered in the PHM both as a categorical
and as a continuous variable. Age had no prognostic value
in the Dukes' C group. In the Dukes' B group, patients
aged above 60 years experienced an increasing hazard with
increasing age. The age dependence was highly significant
(P=0.0004). In patients below 60 years of age no correlation
was found between age and prognosis.
The male/female ratio was 1.28 among the patients with
Dukes' B tumours. Sex had no prognostic value in this
group (P=0.25). In Dukes' C patients, a male/female ratio
of 0.90 was found. Sex was included in the final regression
model with a P value of 0.07 because other authors (e.g.,
Chapuis et al., 1985) have found this to be a prognostic
factor. Females had a better prognosis than males.
Anatomical location of the primary tumour may be char-
acterized in different (highly correlated) ways, e.g., whether
the tumour is located in the rectum or the colon, or by the
Table IV 5-year survival according to tumour size
Dukes' Ba Dukes' C
5-year 5-year Median
survivalb Patients survivaP (years) Patients
0-4cm 64.4+5.7% 101 41.3+7.2% 4.02 78
5-7cm 73.0+4.9% 120 31.6+6.4% 3.32 94
8+ cm 74.7+6.4% 55 16.8+6.0% 2.61 46
(9+ cm 81.5+7.3% 28)
aMedian survival not evaluable; bTest-for-trend (X2=2.55, P=0.11); cTest-for-trend
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Table V Scoring of covariates in PHM analysis
Covariate Scores
Agea Actual age if _60y.
Set equal to 60y if age <60y
Sex 1: Male 0: Female
Localizationb 1: dist.. 10cm 0: dist.> 10cm
Complicating disease 1: Yes 0: No
Resection of
neighbour organs 1: Yes 0: No
Histologic gradec 1: IV+III 0: I+II
Perineural invasion 1: Yes 0: No
Venous invasion 1: Yes 0: No
Max. diameter Actual diameter in cm
CEA level: 2: 7.1 +ngml 1, 1: 3.2-7.0ngml -1, 0: 0-3 ngml
aIn addition age _50 y was tested
bMeasured as the tumour's distance
cAlternative scoring tested: 4: IV, 3: III,
as a prognostic factor;
from the anal verge;
2: 11, 1: 1.
Table VI Final regression model
Covariate B s.d. Exp(B) P value
Dukes' B
Perineural invasion 0.769 0.286 2.158 0.004
Tumour localization 0.647 0.253 1.909 0.005
Venous invasion 0.398 0.266 1.488 0.068
CEA level 0.327 0.148 1.387 0.014
Age above 60 0.071 0.021 1.074 0.0004
Dukes' C
Perineural invasion 0.535 0.195 1.708 0.003
Resection other organs 0.444 0.289 1.559 0.062
Venous invasion 0.410 0.196 1.507 0.018
Tumour localization 0.393 0.187 1.482 0.018
Sex 0.284 0.194 1.328 0.072
CEA level 0.207 0.107 1.230 0.026
Max. diameter 0.039 0.018 1.039 0.018
The prognostic index
location ofthe tumour relative to the peritoneal reflection. Here
the distance from the anal verge, evaluated by rectoscopy,
was used. A distance > 1Ocm was associated with an
improved prognosis in both Dukes' B and C patients
(P=0.005 and P=0.018, respectively).
Tumour size, evaluated as the largest linear diameter of
the tumour, was not a statistically significant prognostic
factor in Dukes' B tumours. In the Dukes' C tumours
increasing tumour size led to a worsening of the prognosis
(P=0.018). Tumour size in 3 directions was available, but
the maximal diameter had the same prognostic value as the
area or volume measures.
While insignificant in the Dukes' B group (P=0.39), the
necessity of neighbour organ resection was associated with a
poor prognosis in Dukes' C patients (P=0.06).
Complicating disease, i.e., the presence of conditions
assumed to influence the prognosis- but not directly tumour
related - was also tested in the analysis. This covariate had
no statistical significance.
Three histopathological parameters were available for
analysis. Perineural and venous invasion, and histological
grading. Perineural invasion had very strong prognostic
significance in both groups. Both venous and perineural
invasion were strong prognosticators in Dukes' C tumours.
When survival was corrected for these two factors, the
histologic grade had no significant influence on survival
(P=0.16). In Dukes' B tumours a relatively close correlation
(r=0.39 estimated from the empirical covariance matrix) was
found between venous invasion and histological grade. In
view of the importance of venous invasion in Dukes' C
disease, this covariate was given the higher priority and
included in the final model.
Pre-operative CEA level was classified in 3 groups; 0-
3.1 ngml-1, 3.2-7.0 ngml -1 and 7.1 + ngml1. The cutpoints
were chosen to be the median (3.1 ngml-1) and the 75th
percentile (7.1 ngml-1) of the CEA values in the combined
set of Dukes' B and C patients. The hazard rate was found
to increase with increasing CEA. In Dukes' B tumours, a
patient with a plasma CEA above 7.1 ngml-1 (20% of the
Dukes' B cases) had a 1.92 times as high hazard rate as a
patient in the 0-3.1 ngml1 group. Similarly, a Dukes' C
patient with CEA in the highest group (35% of the Dukes'
C cases) had a 1.51 times as high hazard rate as a patient in
the low CEA group.
Radiotherapy was added as a covariate in the final
regression model. In Dukes' B patients the P value for this
covariate was 0.23. The estimated hazard of a patient having
radiotherapy was 1.20 times that of a patient having surgery
only. In Dukes' C patients the P value of the covariate
radiotherapy was 0.46. The estimated hazard of a patient
receiving radiotherapy was 1.02 times that of a patient
having surgery only.
The final regression parameters are presented in Table VI.
From the final regression model individual prognostic fore-
casts may be calculated based on a patient's prognostic
index, i.e., the set of values of the significant prognostic
factors. As an example Table VII presents the estimated
5-yearsurvival foreachoffourhypotheticalpatients. Thesefour
patients are chosen to have very favourable/unfavourable
prognosis in Dukes' B and C respectively. Figure 2 shows
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Figure 2 Range of prognoses predicted by the proportional
hazards model in patients with Dukes' B and Dukes' C tumours.
The patient characteristics of these four hypothetical cases are
given in Table VII.
Table VII Prognostic indices
Dukes' B Good prognosis: No perineural or venous invasion,
CEA<3.1ngml-1, <60 years of age, tumour located
more than 10cm from anal verge.
Estimated 5-year survival 90%.
Poor prognosis: Perineural and venous invasion,
CEA.7.1 ngml- 1, 70 years of age, tumur less than
10cm from anal verge.
Estimated 5-year survival 9%.
Dukes' C Good prognosis. Female, no perineural or venous
invasion, CEA.3.1 ngml-1, tumour diameter 5cm, no
resection of neighbour organs, tumour more than 10cm
from anal verge.
Estimated 5-year survival 62%.
Poor prognosis: Male, with perineural or venous
invasion, CEA.3.1 ngml-1, tumour diameter 10cm,
resection of neighbour organs, tumour less than 10cm
from anal verge.
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the estimated survival functions for the same four cases.
While the most unfavourable cases represent extremes in the
patient population it is interesting that the best prognostic
characteristics were quite frequent. Among the Dukes' B and
C patients 21% and 9%, respectively, had the most favour-
able prognostic index. Estimation of 5-year survival for
patients with other prognostic indices is discussed in the
Appendix.
In an attempt to look for a possible survival benefit from
radiotherapy among patients with a short life expectancy i.e.,
with a high risk of cancer death the Dukes' B and C patients
with a relative hazard above the median were selected. In
these high-risk groups, the survival with and without post-
operative radiotherapy was estimated. The results are given
in Table VIII. No significant differences were found.
Discussion
Dukes' stage is a well-established and very strong prognostic
factor. In the single-parameter analyses Dukes' stage had
stronger influence on prognosis than any other single factor.
However, the prognostic models derived from this analysis
predict a very broad range of prognoses within each stage.
Indeed, prognostically good Dukes' C patients are likely to
do better than prognostically poor Dukes' B patients. Thus,
the regression models suggest very important differences in
prognosis in patients with identical Dukes' stage.
In assessing the prognostic significance of patients' age as
demonstrated in Dukes' B cancer in this analysis, it should
be kept in mind that the survival analysis uses death with
cancer as the endpoint. Thus, the survival calculated here
may be expected to be lower than a standard relative
survival. Still, it is interesting that the present worsening of
prognosis with increasing age contradicts the findings by
Block and Enker (1971) in rectal cancer and by Jensen et al.
(1970) in colon cancer. As pointed out by Sugarbaker et al.
(1985) the improved prognosis with increasing age observed
by these authors may be partly explained by the observation
by Dukes and Bussey (1958) that lower grade of malignancy
is associated with older age. In a multivariate analysis this
confounding effect will be corrected for, but in the current
series prognosis worsened with increasing age also in the
single-parameter analysis (Table III). Interestingly, the multi-
variate analysis by Chapuis et al. (1985) showed the same
result as our analysis.
A poorer prognosis in young patients (below 40 years of
age) could not be demonstrated in the present series. How-
ever, the number of young patients was low, implying a low
power of the test.
Sex had a prognostic value in the series by Chapuis et al.
(1985). However, in the present analysis, this result was not
reproduced in Dukes' B tumours, and in Dukes' C tumours,
sex was the least important of the parameters in the model.
Among the clinical variables, the distance of the tumour
from the anal verge is important in both stages. This is
probably a consequence of difficulty in securing a tumour
free lateral resection margin in low situated tumours. (Quirke
et al., 1986), but a difference in lymphatic drainage between
low and high situated tumours may also influence the
prognosis (Sugarbaker et al., 1985).
A number of authors have failed to demonstrate a clear
relationship between tumour size and prognosis. Spratt and
Table VIII 5-year and median survival in high-risk patientsa
+RT -RT P valuesb
Dukes' Bc 58.0+7.0% 58.8+7.0% N.S. (X1=0.24, P=0.62)
Dukes' C 20.5+6.2% 11.8+5.9% N.S. (Xy=0.7l, P=0.40)
(median) (709 days) (924 days)
aDefined as patients with a relative hazard above the median;
bSignificance tested by the log-rank test. CMedian survival not
evaluable.
Spjut (1967) found a slight tendency of very large tumours
to have an improved prognosis. The same trend (although
not statistically significant at the 5% level) seems to be
found in the Dukes' B tumours in this series. However, after
correction for other patient characteristics, tumour size has
no prognostic value. In patients with large Dukes' C
tumours a tendency towards diminished 5-year-survival is
observed. This tendency becomes significant in the regression
model. The fact that the maximum tumour diameter has the
same discriminative power as area or volume is in accordance
with the findings by Miller et al. (1985).
Recently, Wolmark et al. (1986) analyzed the prognostic
value of three proposed modifications of the classification of
Dukes' C colorectal cancer, viz. the level of histologically
positive nodes, the tumour preparation depth, and the
number of histologically positive nodes. The number of
positive nodes was the strongest prognostic discriminate. No
attempt was made to correct for the effect of other clinical
or histopathological variables. Unfortunately, the number of
histologically positive nodes was not available in our analy-
sis. However, the prognostic index suggested by the present
analysis has higher discriminative power than the number of
positive lymph nodes had in the series of Wolmark et al.
(1986).
Perineural invasion had the strongest impact on survival in
both stages. This is in agreement with Seefeld and Bargen
(1943) who found an increased rate of local recurrences as
well as a decreased 5-year survival in patients with perineural
invasion. Also venous invasion is known to have prognostic
value (Grinnell, 1950). When both perineural and venous
invasion were entered into the PHM the first turned out to
have the strongest prognostic influence.
In addition to being the result of a subjective evaluation,
histologic grade is known to be strongly correlated with
stage in colorectal cancer (Newland et al., 1981), and its
independent prognostic value is questionable. Nevertheless,
Chapuis et al., (1985) performed a PHM analysis of prog-
nostic factors in 709 patients with Dukes' A, B, C, or D
colorectal carcinoma in which clinico-pathological stage was
found to be the strongest prognostic factor, followed by age,
histologic grade, venous invasion, sex, direct spread and the
presence of obstruction. Perineural invasion and CEA were
not included in the analysis.
Jass et al. (1986) also applied the Cox PHM to establish a
histopathological grading system in rectal cancer. Seven-
grade related parameters were entered in a survival analysis
of 447 cases. Lymphocytic infiltration, tubule configuration
and pattern of growth were the strongest prognosticators.
When siage-related parameters were entered into the model,
lymphocytic infiltration, number of involved nodes and
spread through the bowel wall were the most important
parameters. It should be noted that Dukes' stage was
excluded from the model because of its composite nature. In
the current study the intent was to refine rather than to
replace Dukes' classification.
Diverse conclusions have been made concerning the sur-
vival advantage of lymphocytic infiltration (e.g., Svennevig
et al., 1984; Thynne et al., 1980) and the exact mechanism
behind an eventual positive influence on survival remains
unclear (Jass et al., 1986).
Elevated pre-operative CEA has been shown to be corre-
lated with time to recurrence, in Dukes' B and C cancer
(Wanebo, 1978), but has also been shown to be correlated
with other clinical and histopathological factors. The present
multivariate analysis demonstrates an independent effect on
survival of the pre-operative CEA level. Among the 20% of
Dukes' B and the 35% of Dukes' C patients with CEA
concentration above 7.1 ngml- the hazard rate is 1.92 and
1.51 times higher, respectively, than for patients with CEA in
the normal range. In other words CEA concentration is
among the strongest prognosticators investigated in this
study. Furthermore, a semi-quantitative relationship seems
to exist between the hazard rate and the level of CEA.200 S.M. BENTZEN et al.
Cross-validation of this observation in an independent series
would be desirable.
In recent years, a number of immunohistochemical
markers has been suggested in colorectal cancer. This paper
has demonstrated the presence of very strong prognostic
factors in this disease. Therefore a multivariate analysis with
adequate correction for the effect of known clinical and
histological prognosticators is required to assess the indepen-
dent value of any proposed prognosticator.
Numerous studies using historical controls (Green, 1981;
Sichy, 1982; Kopelson, 1983; Hoskins et al., 1985; Tepper et
al., 1987) and the randomized study by Gerard et al. (1985)
have suggested an improved local control after radiotherapy
in colorectal cancer. However, the randomized study by the
Gastrointestinal Study Group (1985) showed no significant
difference in time to tumour recurrence between the radia-
tion plus surgery (50 pts) and the surgery-alone (58 pts)
arms. Only when chemotherapy and radiotherapy were com-
bined in the adjuvant treatment a significant difference in
time to recurrence was found. Overall survival did not differ
significantly among the treatment arms. The present analysis
could not demonstrate any positive effect on survival after
post-operative radiotherapy. Without entering the discussion
on the methodological problems of using historical controls,
it is interesting to note that the lack of difference in survival
between the two arms in this study seems to spring not from
a poor (relative to that of other studies) result in the
radiotherapy arm but rather from a good result in the
surgery-alone arm. Thus, if appropriate surgery is per-
formed, radiotherapy seems to have no positive effect on
survival. Delivering the radiation as a split course may have
reduced the efficacy of the treatment. However, the actual
importance of overall treatment time in radiotherapy of
colorectal cancer remains an open question. The relevance of
radiotherapy should not be judged solely from its influence
on survival. Local control is of obvious importance to the
patient and is a more sensitive clinical endpoint for measur-
ing the effect of radiotherapy. Furthermore, an analysis
of local control might be of value in identifying subsets of
patients in which intensified local treatment would be indi-
cated. An analysis of this endpoint with correction for other
prognostic factors awaits a revision of the database.
In conclusion, clinical and histopathological variables
collected prospectively in a randomized multi-centre study of
post-operative radiotherapy in Dukes' B and C colorectal
cancer were evaluated with respect to their prognostic
importance using death with cancer as the endpoint. From
the set of available parameters a proportional hazards model
was derived containing parameters with an independent,
significant influence on prognosis. Based on these models a
prognostic forecast may be made in individual patients with
Dukes' B or C tumours. The construction of such a model is
an important step towards the definition of high-risk patients
requiring more aggressive adjuvant therapy. Furthermore,
such prognostic models may add important knowledge to the
understanding of the natural history of the disease.
Retrospective analyses ofprognostic factors will often miss
data on one or more clinicopathological variables of pos-
sible importance. However, such studies are very important
in defining the set of parameters that ought to be included
in a prospective study. There is no doubt that a complete
prognostic model in colorectal cancer should include both
clinical and pathological parameters together with pre-
operative CEA. Several of these variables are correlated,
thus allowing different subsets of these to define prognostic
models with equal discriminative power. The priority given to
prognostic factors should not only reflect their prognostic
value but also take their inter-observer reproducibility and
their mutual independence into account. Other factors
influencing the priority ofprognosticators are convenience to
the patient, ease of measurement and the cost of
measurement.
The CRES study was initiated to investigate the possible
effect of post-operative radiotherapy. No such effect was
demonstrated. In the present paper, the survival benefit from
radiotherapy was tested with correction for known prognos-
tic factors. No such benefit could be demonstrated. Finally,
the effect of radiotherapy was tested among high risk Dukes'
B and Dukes' C patients. Once again radiotherapy as
administered in the CRES protocol had no positive effect on
patient survival.
Although avoiding cancer death is the major goal in
cancer treatment, the quality of life of the patients is another
very important consideration. One remaining question is
whether radiotherapy will prolong the time to the first local
recurrence. An early analysis of this series suggested that this
may be the case in Dukes' C tumours. However, a renewed
careful analysis of the material with extended observation
time cast doubt on this finding.
It is remarkable that the predicted 5-year survival rates
ranged from 9% to 90% and from 0% to 62% in subgroups
of patients with Dukes' B and Dukes' C tumours respec-
tively. Although the worst prognoses represent limiting cases
in the patient population, subsets of Dukes' B and C
patients with very short expected lifetime have been identi-
fied in the present analysis. An increased effort towards a
more aggressive adjuvant therapy in these patients is strongly
needed.
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Appendix: Calculation of prognostic forecasts from the regression
model
The prognostic best cases in Table VII may be used as reference
cases for calculating the prognosis in patients with other prognostic
indices. This is accomplished using the regression parameters in Table
VI and the estimated 5-year survival for the prognostic most
favourable cases from Table VII. The estimated survival should be
taken as a fraction of one, i.e., 0.90 for Dukes' B and 0.62 for
Dukes' C. There are three steps in the procedure:
First, write down the values of the covariates for the actual case
using the codes from Table V. Only age (Dukes' B) and maximum
tumour diameter (Dukes' C) require a slightly different procedure.
The covariate describing the prognostic effect of age is set equal to
zero for patients below 60 years of age, and equal to the actual age
minus 60 years for patients above 60 years of age (e.g., equal to 13
for a 73-year-old patient). The covariate describing the effect of
tumour size is set equal to the maximum tumour diameter measured
in cm minus 5cm (the reference size for the best case in Table VII),
e.g., equal -3 for a 2cm diameter tumour.
Second, multiply the value of each covariate with the correspond-
ing B-value from Table VI and add together all these products. Let s
denote the resulting sum.
Third, calculate exp(s) and raise the 5-year survival from Table
VII to this power. The result is the estimated survival for the actual
case, again expressed as a fraction of one.
Example. Calculate the estimated 5-year survival for a 65-year-old
patient with a Dukes' B tumour, a pre-operative CEA level of
8ngml- and with venous invasion. There is no perineural invasion
and the tumour is located more than 10cm from the anal verge.
Solution: First note that there is no contribution from the covariates
describing perineural invasion and localization as these agree with
the values for the prognostic best case. The covariate for venous
invasion is equal to one, for age the covariate is equal to 5 (actual
age minus 60 years), and for CEA it is 2. Thus s is
s=0.398 1+0.071
- 5+0.327 *2= 1.407
and exp(s) becomes 4.08. The estimated 5-year survival for the
actual case is then the 5-year survival for the prognostic best case
raised to the power 4.08, i.e., (0.90)4.08 =0.65 or 65%.PROGNOSTIC FACTORS IN COLORECTAL CANCER 201
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